Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML

Overview of attention for article published in Experimental Hematology & Oncology, January 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML. https://t.co/zhjuphUL1f #AML #leusm #hematology https://t.co/uiHvJoZ0Vb

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.